Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia.
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000172:deficiency*; D001479:Basal Ganglia / Q000378:metabolism; D016022:Case-Control Studies; D003401:Creatine / Q000172:deficiency; D005260:Female; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D008297:Male; D010725:Phosphocreatine / Q000172:deficiency; D017397:Prefrontal Cortex / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*
D014150:Antipsychotic Agents; D010725:Phosphocreatine; D001224:Aspartic Acid; C000179:N-acetylaspartate; D003401:Creatine